Congenital aniridia - A comprehensive review of clinical features and therapeutic approaches.

Surv Ophthalmol

Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

Published: March 2022

Congenital aniridia is a rare genetic eye disorder with total or partial absence of the iris from birth. In most cases the genetic origin of aniridia is a mutation in the PAX6 gene, leading to involvement of most eye structures. Hypoplasia of the fovea is usually present and is associated with reduced visual acuity and nystagmus. Aniridia-associated keratopathy, glaucoma, and cataract are serious and progressive complications that can further reduce visual function. Treatment of the ocular complications of aniridia is challenging and has a high risk of side effects. New approaches such as stem cell therapy may, however, offer better prognoses. We describe the various ocular manifestations of aniridia, with a special focus on conditions that commonly require treatment. We also review the growing literature reporting systemic manifestations of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.survophthal.2021.02.011DOI Listing

Publication Analysis

Top Keywords

congenital aniridia
8
aniridia comprehensive
4
comprehensive review
4
review clinical
4
clinical features
4
features therapeutic
4
therapeutic approaches
4
approaches congenital
4
aniridia
4
aniridia rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!